Top Markets
Coin of the day
CRISM Therapeutics Corporation CRISM Therapeutics Corporation

CRISM Therapeutics Corporation

CRTX
Hisse Senetlerindeki Sıralama #40984
CRISM Therapeutics Corporation is dedicated to developing innovative drug... CRISM Therapeutics Corporation is dedicated to developing innovative drug delivery systems that enhance the effectiveness of cancer medications targeting solid tumors. Their primary offering, ChemoSeed, is designed for direct insertion into a tumor or the surgical site post-tumor removal, ensuring that therapeutic concentrations of chemotherapy agents are precisely localized to the cancerous tissue. This technology finds particular application in treating gliomas, a form of brain tumor. The company was established in 2016 and is headquartered in Road Town, British Virgin Islands.
Hisse Fiyatı
$0.14967717
Piyasa Değeri
$57.63K
Değişim (1 gün)
10.00%
Değişim (1 yıl)
4.98%
Ülke
VG
Ticaret CRISM Therapeutics Corporation (CRTX)

Kategori

CRISM Therapeutics Corporation (CRTX) için EPS
2026 itibariyle EPS TTM: 0
CRISM Therapeutics Corporation şirketinin en son finansal raporlarına ve hisse senedi fiyatına göre, şirketin mevcut EPS'si (TTM) 0'dir. 2026 yılı sonunda, şirketin EPS'si 0 idi; bu, 2026 yılındaki EPS olan 0 ile önceki yıla eşit.
CRISM Therapeutics Corporation için 2026 - 2026 arasındaki EPS geçmişi
Her yıl sonunda EPS
Yıl EPS Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için EPS